Clinical Trials on Psychophysiologic Insomnia in Poland

Total 54 results

Oregon Health and Science University

Completed

Improving Sleep Quality in People With Insomnia

Primary Insomnia | Psychophysiological Insomnia

United States
Leiden University
BioClock Consortium; Caring Univeristies

Completed

Feasibility Trial i-Sleep & BioClock Intervention

Insomnia

Netherlands
Butler Hospital
Sunovion

Completed

Eszopiclone Treatment & Cortisol Responsivity

Insomnia

United States
Wroclaw Medical University

Enrolling by invitation

Relationship Between Selected Parameters and Bruxism (WMU1/2019)

Pain | Sleep Disorder | Anxiety | Temporomandibular Disorder | Sleep Bruxism | Mental Status Change | Psychosomatic Disorder

Poland
Sanofi

Completed

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties (ECLIPSE)

Primary Insomnia

United States, France, Canada, Poland, Germany, Hungary, Austria
National University of Natural Medicine

Completed

Remote Yoga Nidra for Anxiety and Sleep

Insomnia Due to Anxiety and Fear

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder

Insomnia Disorders

Belgium, United States, Germany, Poland, Japan, France
Eli Lilly and Company

Completed

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia (SLUMBER)

Primary Insomnia | Secondary Insomnia

United States
California Pacific Medical Center Research Institute
Patient-Centered Outcomes Research Institute; University of Pittsburgh; University... and other collaborators

Active, not recruiting

CBT-I or Zolpidem/Trazodone for Insomnia (COZI)

Chronic Insomnia

United States
University of Amsterdam

Recruiting

Acceptance and Commitment Therapy for Insomnia

Insomnia

Netherlands
VU University of Amsterdam

Completed

Sleep Restriction Treatment for Insomnia

Insomnia

Netherlands
VU University of Amsterdam
Slaapmakend

Completed

Online or Face-to-face Treatment for Insomnia?

Insomnia

Netherlands
VU University of Amsterdam

Completed

Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions

Insomnia

Netherlands
Wroclaw Medical University

Enrolling by invitation

Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea

Cardiovascular Diseases | Sleep Disorder | Insomnia | Sleep Apnea | Sleep Bruxism | Comorbidities and Coexisting Conditions

Poland
Kaiser Permanente
National Institute of Mental Health (NIMH)

Completed

CBT Insomnia Teens: Augmenting SSRIs to Improve Youth Depression (SleepWell)

Depression | Insomnia

United States
Kaiser Permanente
University of California, Berkeley

Completed

Young Adult and Teen Sleep Study (YATSS)

Depression | Insomnia

United States
Oregon Health and Science University

Terminated

Melatonin for Circadian Sleep Disorders in the Blind

Insomnia | Blindness | Daytime Sleepiness

United States
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Insomnia Disorder

United States, Germany, Spain, Hungary, Israel, Sweden
Eisai Inc.

Completed

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Insomnia Disorder

United States, Canada, Finland, Germany, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Spain
Uppsala University

Not yet recruiting

Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis

Multiple Sclerosis | Insomnia

Sweden
Pfizer

Completed

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Insomnia

United States, Canada
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Insomnia Disorder

United States, Germany, Canada, Denmark, Poland, Spain, Switzerland, Belgium, Bulgaria, Finland, France, Hungary, Korea, Republic of, Sweden
Rhode Island Hospital

Completed

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

Insomnia Disorder

United States, Germany, Australia, Canada, Denmark, Italy, Poland, Serbia, Spain, Switzerland
GlaxoSmithKline

Completed

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

Insomnia | Sleep Initiation and Maintenance Disorders

United States, Canada
Takeda

Completed

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

Chronic Insomnia

United States
Eisai Inc.

Completed

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

Insomnia

United States
Takeda

Terminated

Efficacy of Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Eisai Inc.

Completed

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) (SUNRISE 1)

Insomnia

United States, Spain, United Kingdom, Italy, Germany, France, Canada
Vanda Pharmaceuticals

Completed

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Insomnia

United States
Takeda

Completed

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Chronic Insomnia

United States, Canada
Idorsia Pharmaceuticals Ltd.

Recruiting

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Insomnia

Spain, United States, Belgium, Germany, Bulgaria
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

Transient Insomnia

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Insomnia Disorder

United States, Korea, Republic of, Germany, Belgium, Bulgaria, Canada, Czechia, Finland, France, Hungary, Sweden
GlaxoSmithKline

Completed

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

Insomnia | Sleep Initiation and Maintenance Disorders

United States
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Completed

Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors (YOCAS-II)

Insomnia | Cancer Survivor | Malignant Neoplasm

United States
VA Office of Research and Development

Recruiting

National Adaptive Trial for PTSD Related Insomnia (NAP)

Insomnia

United States
Takeda

Completed

Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia

Insomnia

United States
Takeda

Completed

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Midnight Pharma, LLC

Completed

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia (RESTORA 1)

Primary Insomnia

Spain, Germany, Belgium, France, United Kingdom, Australia, Austria, Bulgaria, Czech Republic, Denmark, Finland, Hungary, Israel, Italy, Poland, Slovakia, South Africa, Sweden, Switzerland, Ukraine
Sunovion

Completed

Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

Insomnia

United States
Takeda

Completed

Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Chronic Insomnia

United States
Sunovion

Completed

6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia

Primary Insomnia

United States
Sunovion

Completed

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Insomnia

United States
Takeda

Completed

Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Sunovion

Completed

A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia

Insomnia | Major Depressive Disorder

France, Poland, Russian Federation, United Kingdom, Austria, Hungary, Croatia, Romania, Serbia, Ukraine
Sunovion

Completed

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Sunovion

Completed

Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

Insomnia | Generalized Anxiety Disorder

United States
Sunovion

Completed

A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Insomnia | Depressive Disorder, Major

United States

Clinical Trials on Psychophysiologic Insomnia in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations